Emergency? Call 911 671-645-5500
TJC Accredited
3 consecutive terms
Best Off-Base Hospital
Stars & Stripes Newspaper
Advanced Primary Stroke Center
By the Joint Commission

Infectious Disease

Detail about our service
GRMC Lung & Infectious Disease(GLID) Center

About Our Infectious Disease Services


GRMC Lung and Infectious Disease (GLID) Center was established in 2022 as Guam’s first hybrid Specialty Center to address the island’s need for comprehensive Respiratory and Infectious Disease care.

Michele Yamamoto, MD

Dr. Michele Yamamoto is a specialist in Infectious Diseases. She came to Guam in 2016 after completing a Clinical Fellowship in Infectious Diseases at the University of Massachusetts Medical Center. She served her residency at the Memorial hospital of Rhode Island, Brown University and graduated from the University of Santo Tomas in Manila, Philippines. 

Dr. Yamamoto specializes in the diagnosis and treatment of various infectious diseases including HIV/AIDS and infections in the immunocompromised host. She works closely with the Guam DPH Tuberculosis program in the diagnosis and treatment of active Tuberculosis cases. 

Dr. Yamamoto is double-Board Certified in Infectious Diseases and Internal Medicine from the American Board of Internal Medicine. She also serves as GRMC’s head of Antimicrobial Stewardship and Infection Control Program. 


  • Non-Tuberculous Mycobacteria
  • Active and latent Tuberculosis management
  • Infections in the immunocompromised host including transplant patients
  • HIV / AIDS
  • Hepatitis B and Hepatitis C
  • Sexually transmitted diseases
  • General infectious disease to include intra-abdominal, blood, bone and joint, central nervous system and urinary system infections

Procedures offered

  • Out-patient IV antibiotic management (OPAT
  • Latent Tb clinic DOT

For further inquiries you may visit our website at www.glidcenter.com

GRMC Lung & Infectious Disease(GLID) Center

Our Doctors

Michele Yamamoto, M.D.

Infectious Disease

NOTICED: Our website is currently under construction to provide you with an improved and user-friendly platform. We apologize for any inconvenience.